Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 994 entries
View as:

Osteonecrosis of the Jaw (ONJ) Case Registry

Phase: N/A Priority: Normal
NCT ID: NCT01666106 Org: User:
Start: 10/01/12 End: 12/16/20 Due: 12/16/21

Ascending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine Patients

Phase: N/A Priority: Normal
NCT ID: NCT01688739 Org: User:
Start: 03/13/12 End: 03/27/13 Due: 03/27/14

Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary Nailing

Phase: N/A Priority: Normal
NCT ID: NCT00907296 Org: User:
Start: 09/02/09 End: 05/10/13 Due: 05/10/14

Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL

Phase: N/A Priority: Normal
NCT ID: NCT04524455 Org: User:
Start: 10/02/20 End: 01/24/23 Due: 01/24/24

Etanercept SFP in RA Patients

Phase: N/A Priority: Normal
NCT ID: NCT00413452 Org: User:
Start: 12/31/06 End: 10/31/07 Due: 10/31/08

Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders (UCDs)

Phase: N/A Priority: Normal
NCT ID: NCT03335488 Org: User:
Start: 02/20/18 End: 12/20/22 Due: 12/20/23

A Phase 3 Study of Rilotumumab (AMG 102) With Cisplatin and Capecitabine (CX) as First-line Therapy in Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02137343 Org: User:
Start: 07/31/14 End: 06/30/15 Due: 06/30/16

Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept

Phase: N/A Priority: Normal
NCT ID: NCT01875991 Org: User:
Start: 06/05/13 End: 03/04/14 Due: 03/04/15

LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy

Phase: N/A Priority: Normal
NCT ID: NCT01380730 Org: User:
Start: 07/01/11 End: 04/05/12 Due: 04/05/13

A Multi-Center, Randomized, Open-Label Study to Assess the Immunogenicity and Safety of Denosumab in Pre-filled Syringe Compared to Vial in Subjects With Low Bone Mineral Density

Phase: N/A Priority: Normal
NCT ID: NCT00515463 Org: User:
Start: 05/31/07 End: 03/31/09 Due: 03/31/10

Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast

Phase: N/A Priority: Normal
NCT ID: NCT02749370 Org: User:
Start: 05/18/16 End: 12/06/17 Due: 12/06/18

Study to Evaluate the Safety, PK, PD and Efficacy of AMG 827 in Adults With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00771030 Org: User:
Start: 10/27/08 End: 05/25/10 Due: 05/25/11

Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00521339 Org: User:
Start: 08/01/07 End: 05/01/09 Due: 05/01/10

Effect of Denosumab on Cellular Biomarkers in the Human Breast

Phase: N/A Priority: Normal
NCT ID: NCT02099461 Org: User:
Start: 04/30/14 End: 07/31/14 Due: 07/31/15

Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)

Phase: N/A Priority: Normal
NCT ID: NCT00099554 Org: User:
Start: 05/31/04 End: - Due: -

Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT03164928 Org: User:
Start: 05/07/18 End: 12/20/23 Due: 12/20/24

A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases

Phase: N/A Priority: Normal
NCT ID: NCT02780674 Org: User:
Start: 08/26/16 End: 11/27/17 Due: 11/27/18

A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease

Phase: N/A Priority: Normal
NCT ID: NCT02473445 Org: User:
Start: 05/19/15 End: 03/06/17 Due: 03/06/18

Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)

Phase: N/A Priority: Normal
NCT ID: NCT06180278 Org: User:
Start: 04/02/24 End: 06/02/28 Due: 06/02/29

An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03777436 Org: User:
Start: 02/11/19 End: 02/09/22 Due: 02/09/23

Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04478695 Org: User:
Start: 09/29/20 End: 10/23/20 Due: 10/23/21

A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Apremilast

Phase: N/A Priority: Normal
NCT ID: NCT01561963 Org: User:
Start: 02/01/12 End: 04/01/12 Due: 04/01/13

Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia

Phase: N/A Priority: Normal
NCT ID: NCT02415127 Org: User:
Start: 06/30/15 End: 11/30/16 Due: 11/30/17

A Study to Evaluate ABP 938 and Aflibercept (Eylea®) in Participants With Chorioretinal Vascular Disease (CVD)

Phase: N/A Priority: Normal
NCT ID: NCT05704725 Org: User:
Start: 01/23/23 End: 03/24/23 Due: 03/24/24

Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01416428 Org: User:
Start: 10/15/11 End: 08/12/19 Due: 08/12/20